Silence Therapeutics (SLN) Receivables (2019 - 2025)
Historic Receivables for Silence Therapeutics (SLN) over the last 7 years, with Q3 2025 value amounting to $28000.0.
- Silence Therapeutics' Receivables fell 9251.73% to $28000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $28000.0, marking a year-over-year decrease of 9251.73%. This contributed to the annual value of $972000.0 for FY2024, which is 24348.4% up from last year.
- Per Silence Therapeutics' latest filing, its Receivables stood at $28000.0 for Q3 2025, which was down 9251.73% from $85000.0 recorded in Q2 2025.
- Over the past 5 years, Silence Therapeutics' Receivables peaked at $15.4 million during Q2 2023, and registered a low of $28000.0 during Q3 2025.
- Moreover, its 5-year median value for Receivables was $612205.0 (2021), whereas its average is $2.5 million.
- Its Receivables has fluctuated over the past 5 years, first soared by 49673.97% in 2022, then crashed by 9960.29% in 2025.
- Silence Therapeutics' Receivables (Quarter) stood at $446191.5 in 2021, then surged by 140.53% to $1.1 million in 2022, then crashed by 73.63% to $282982.6 in 2023, then surged by 243.48% to $972000.0 in 2024, then plummeted by 97.12% to $28000.0 in 2025.
- Its Receivables stands at $28000.0 for Q3 2025, versus $85000.0 for Q2 2025 and $41000.0 for Q1 2025.